Archive — US — techcrunch
Latent Labs launches web-based AI model to democratize protein design
Latent Labs has launched LatentX, a web-based AI model aimed at democratizing protein design, offering academic and biotech institutions the ability to create novel proteins directly in their browser. With $50M in backing, the model has reached state-of-the-art performance and allows for the design of complex proteins beyond natural variants, differing from AlphaFold by enabling actual protein generation.
Key points
- Latent Labs emerged from stealth with $50M funding.
- Launched LatentX, a user-friendly AI model for protein design.
- Achieved state-of-the-art performance in lab-tested proteins.
- Enables creation of new molecules like nanobodies and antibodies.
- Distinction from AlphaFold: LatentX generates new proteins, while AlphaFold visualizes existing structures.
- Business model focuses on licensing the tool to external organizations.
- LatentX currently free but plans to monetize advanced features.
Why it matters
- The rise of AI in drug discovery aligns with the 2025 trend of integrating AI technologies into healthcare.
- Historical context: AlphaFold's introduction catalyzed innovations in protein structure prediction, paving the way for generative models like LatentX.
- Shift towards democratizing advanced technologies in biotech reflects broader 2025 IT trends focusing on accessibility and collaboration.
Latent Labs' LatentX represents a significant advancement in protein design, exemplifying the trend of making AI tools accessible for both academia and industry, and could greatly accelerate therapeutic development in the coming years.